/PRNewswire/ Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch.
Get latest articles and stories on Business at LatestLY. Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. Business News | Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease.
LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
Munster, [Germany], July 30 (ANI/PRNewswire): LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug-Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease) has already enrolled 15 patients, which is encouraging as the Company looks to take a leap in the peripheral artery disease (PAD) treatment. Initiated by the University Hospitals Jena and Leipzig in Germany and led by Principal Investigator (PI) Prof. Dr Ulf Teichgraber alongside Co-PI Prof. Thomas Zeller and Prof. Dierk Scheinert, LIMES is a prospective, multicentre, randomized controlled trial (RCT) which is designed and aimed to evaluate Magic Touch - PTA 0.014" and 0.018" (Concept Medical Inc) versus POBA (Plain Old Balloon Angioplasty) in a head-to-head comparison (1:1). The trial kicked off with the index patient enrolled on 31st March 2022 by PD Dr Nassan Malyar at the Universit